SCHEMBL31697865

SCHEMBL31697865

Cc1ccc(C(=O)N2CCC(COCCC3CCNCC3)CC2)cc1N1CCC(=O)NC1=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RBP4 P02753 1/20 0.39
▸ GFER P55789 1/20 0.38
▸ DDB1 Q16531 4/20 0.38
▸ CRBN Q96SW2 4/20 0.38
▸ FASN P49327 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ TP53 P04637 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ KMT2A Q03164 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HTR7 P34969 1/20 0.34
▸ MGLL Q99685 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ SMYD3 Q9H7B4 1/20 0.34
▸ EGLN1 Q9GZT9 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29281606 0.92 DDB1 (0.38) GFERDDB1CRBNALDH1A1TP53
SCHEMBL27137025 0.90 RBP4 (0.38) RBP4CRBNALDH1A1HPGDKMT2A
SCHEMBL27123888 0.90 MGLL (0.39) RBP4MGLLHSD11B1
SCHEMBL31697885 0.90 MGLL (0.39) RBP4MGLLHSD11B1
SCHEMBL31697794 0.89 GPR119 (0.41) DDB1CRBNKMT2A
SCHEMBL30015004 0.88 RBP4 (0.38) RBP4HTR7MGLLHSD11B1
SCHEMBL27137731 0.88 RBP4 (0.38) RBP4HTR7MGLLHSD11B1
SCHEMBL30014591 0.88 MGLL (0.38) RBP4MGLLHSD11B1
SCHEMBL27148092 0.88 MGLL (0.38) RBP4MGLLHSD11B1
SCHEMBL27124624 0.83 MGLL (0.41) RBP4MGLLHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4631942-A1 PAN-KRAS DEGRADING AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) 2025-10-15 — — EP disclosed
Send feedback